SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-134894
Filing Date
2020-05-06
Accepted
2020-05-06 16:10:43
Documents
60
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d881162d10q.htm   iXBRL 10-Q 1785860
2 EX-10.5 d881162dex105.htm EX-10.5 32832
3 EX-10.6 d881162dex106.htm EX-10.6 17727
4 EX-31.1 d881162dex311.htm EX-31.1 10740
5 EX-31.2 d881162dex312.htm EX-31.2 10785
6 EX-32.1 d881162dex321.htm EX-32.1 6206
  Complete submission text file 0001193125-20-134894.txt   6073022

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA gbt-20200331.xsd EX-101.SCH 34442
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbt-20200331_cal.xml EX-101.CAL 37876
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbt-20200331_def.xml EX-101.DEF 144335
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20200331_lab.xml EX-101.LAB 341207
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20200331_pre.xml EX-101.PRE 262183
49 EXTRACTED XBRL INSTANCE DOCUMENT d881162d10q_htm.xml XML 1027372
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 20852709
SIC: 2834 Pharmaceutical Preparations